These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 27887917)

  • 1. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
    Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
    Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch3-specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel-resistant ovarian cancer cells.
    Kang H; Jeong JY; Song JY; Kim TH; Kim G; Huh JH; Kwon AY; Jung SG; An HJ
    Mol Carcinog; 2016 Jul; 55(7):1196-209. PubMed ID: 26207830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.
    Eoh KJ; Lee SH; Kim HJ; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    Biochem Biophys Res Commun; 2018 Mar; 497(2):513-520. PubMed ID: 29452092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
    J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3.
    Kim TH; Jeong JY; Park JY; Kim SW; Heo JH; Kang H; Kim G; An HJ
    Oncotarget; 2017 Sep; 8(42):72788-72800. PubMed ID: 29069826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD; Li XS; Meng XN; Yan J; Zong ZH
    Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.
    Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama S; Otsuki Y; Miyazaki K
    Am J Clin Pathol; 2012 Oct; 138(4):535-44. PubMed ID: 23010708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis.
    Park ST; Byun HJ; Kim BR; Dong SM; Park SH; Jang PR; Rho SB
    Biochem Biophys Res Commun; 2013 May; 435(1):153-9. PubMed ID: 23628417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.
    d'Adhemar CJ; Spillane CD; Gallagher MF; Bates M; Costello KM; Barry-O'Crowley J; Haley K; Kernan N; Murphy C; Smyth PC; O'Byrne K; Pennington S; Cooke AA; Ffrench B; Martin CM; O'Donnell D; Hennessy B; Stordal B; Finn S; McCann A; Gleeson N; D'Arcy T; Flood B; O'Neill LA; Sheils O; O'Toole S; O'Leary JJ
    PLoS One; 2014; 9(6):e100816. PubMed ID: 24977712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.
    Zhang H; Zuo Z; Lu X; Wang L; Wang H; Zhu Z
    Oncol Rep; 2012 Feb; 27(2):594-8. PubMed ID: 22076535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
    Jeong JY; Kim KS; Moon JS; Song JA; Choi SH; Kim KI; Kim TH; An HJ
    Apoptosis; 2013 Apr; 18(4):509-20. PubMed ID: 23371322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer.
    Chen J; Chen Y; Chen Z
    Cancer Invest; 2013 Jan; 31(1):17-23. PubMed ID: 23327190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.
    Huh JH; Kim TH; Kim K; Song JA; Jung YJ; Jeong JY; Lee MJ; Kim YK; Lee DH; An HJ
    Br J Cancer; 2013 Jul; 109(2):452-61. PubMed ID: 23807165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells.
    Shuang T; Wang M; Shi C; Zhou Y; Wang D
    FEBS Lett; 2015 Oct; 589(20 Pt B):3154-64. PubMed ID: 26363097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor.
    Zhou Y; Wang M; Shuang T; Liu Y; Zhang Y; Shi C
    Pathol Res Pract; 2019 Oct; 215(10):152606. PubMed ID: 31500928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-128/homeobox B8 axis regulates ovarian cancer cell progression.
    Li R; Gong L; Li P; Wang J; Bi L
    Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):499-507. PubMed ID: 31271703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis.
    Chatterjee A; Chattopadhyay D; Chakrabarti G
    Cell Signal; 2015 Feb; 27(2):189-203. PubMed ID: 25435430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.